Feedback / Questions
sabirnetug IV (ACU193 IV) - Acumen Pharma
https://www.globenewswire.com/news-release/2025/04/02/3054096/0/en/Acumen-Pharmaceuticals-Showcases-pTau217-Trial-Screening-Progress-in-Phase-2-ALTITUDE-AD-Trial-and-Preclinical-Research-Methods-at-AD-PD-2025-and-AAN-Annual-Meeting.html
Apr 2, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next